Skip to main content
Journal ArticleOPEN ACCESS

R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies

  • Echenique I
  • Castillo J
Infectious Agents and Cancer (2012) 7(S1)
DOI: 10.1186/1750-9378-7-s1-p22
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The article presents a study which compares the effectiveness of chemotherapeutic (CHOP) and rituximab added to CHOP (R-CHOP) in treating HIV-associated lymphoma. The authors identified three studies on HIV-related lymphoma treated with R-CHOP and nine studies with CHOP. They concluded that patients with HIV-related lymphoma treated with R-CHOP had higher odds for complete response and 2-year over-all survival when compared to CHOP.

Cite

CITATION STYLE

APA

Echenique, I., & Castillo, J. (2012). R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies. Infectious Agents and Cancer, 7(S1). https://doi.org/10.1186/1750-9378-7-s1-p22

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free